Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers

BACKGROUND: For women carrying a germline pathogenic or likely pathogenic variant in the BRCA1/2 genes, having a pregnancy following breast cancer diagnosis and treatment is safe. However, no evidence exists on the safety of having a subsequent pregnancy in BRCA carriers with a prior diagnosis of br...

Descripción completa

Detalles Bibliográficos
Autores: Perachino, M, Blondeaux, E, Delucchi, V, Bernstein Molho, R, Frank, S, Paluch-Shimon, S, Linn, S, Di Meglio, Antonio, Peccatori, F, Moore, H C F, Parokonnaya, A, Renaud, T, Rodriguez Wallberg, K A, Partridge, A H, Pogoda, K, Ferrari, A, Wildiers, H, Toss, A, Rousset-Jablonski, C, Kim, H J, Varela, M, Córdoba Cardona, Octavi, Tanase Damian, C, Marhold, M, Fabi, A, Graff, S L, Rodriguez-Hernandez, A, Okano, M, Duchnowska, R, Luna Pais, H, Di Rocco, R, Azim, H A, Mariamidze, E, Kourie, H R, Arecco, L, Carrasco, Estela, Agostinetto, E, Balmana, J, Saura, C, Lambertini, M
Tipo de recurso: artículo
Fecha de publicación:2025
País:España
Institución:Conselleria de Salut i Consum del Govern de les Illes Balears
Repositorio:Docusalut
Idioma:inglés
OAI Identifier:oai:docusalut.com:20.500.13003/25716
Acceso en línea:https://hdl.handle.net/20.500.13003/25716
Access Level:acceso abierto
Palabra clave:BRCA
breast cancer
oncofertility
pregnancy
survivorship
id ES_5115b4b353f25f4b7eecfa9dbeae5efa
oai_identifier_str oai:docusalut.com:20.500.13003/25716
network_acronym_str ES
network_name_str España
repository_id_str
spelling Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriersPerachino, MBlondeaux, EDelucchi, VBernstein Molho, RFrank, SPaluch-Shimon, SLinn, SDi Meglio, AntonioPeccatori, FMoore, H C FParokonnaya, ARenaud, TRodriguez Wallberg, K APartridge, A HPogoda, KFerrari, AWildiers, HToss, ARousset-Jablonski, CKim, H JVarela, MCórdoba Cardona, OctaviTanase Damian, CMarhold, MFabi, AGraff, S LRodriguez-Hernandez, AOkano, MDuchnowska, RLuna Pais, HDi Rocco, RAzim, H AMariamidze, EKourie, H RArecco, LCarrasco, EstelaAgostinetto, EBalmana, JSaura, CLambertini, MBRCAbreast canceroncofertilitypregnancysurvivorshipBACKGROUND: For women carrying a germline pathogenic or likely pathogenic variant in the BRCA1/2 genes, having a pregnancy following breast cancer diagnosis and treatment is safe. However, no evidence exists on the safety of having a subsequent pregnancy in BRCA carriers with a prior diagnosis of breast cancer during pregnancy (PrBC). METHODS: The BRCA BCY Collaboration (NCT03673306) is an international, multicenter, retrospective cohort study that included BRCA carriers diagnosed with invasive breast cancer at the age ≤40 years between January 2000 and December 2020. This analysis included only women diagnosed with PrBC comparing patients who had a subsequent pregnancy to those without. Primary endpoints were the cumulative incidence of having a subsequent pregnancy and disease-free survival (DFS). Secondary endpoints were overall survival, pattern of first DFS events and reproductive outcomes. RESULTS: Of 6238 BRCA carriers from 109 centers worldwide, 282 patients with PrBC were included in this analysis, of whom 68 had a subsequent pregnancy and 214 did not. The 10-year cumulative incidence of having a subsequent pregnancy was 36.6% [95% confidence interval (CI) 29.5% to 44.8%]. Patients with a subsequent pregnancy were more likely to be younger at diagnosis (median age 31 years versus 34 years) and to have triple-negative tumors (73.5% versus 55.1%). Among patients with a subsequent pregnancy, median time from diagnosis to conception was 3.3 years (interquartile range 2.0-4.3 years). Most pregnancies were delivered at term (≥37 weeks, 75.9%) and without complications (74.1%). Median follow-up was 7.3 years (interquartile range 4.5-11.9 years). No differences in DFS (adjusted hazard ratio (HR) 1.06, 95% CI 0.49-2.31) nor overall survival (adjusted HR 0.63, 95% CI 0.19-2.05) were observed between patients with or without a subsequent pregnancy. CONCLUSIONS: In this global study, one out of three young BRCA carriers diagnosed with PrBC had a subsequent pregnancy. No concerning signals in terms of maternal prognosis or reproductive outcomes were observed.Elsevier20252025-08-1320252025-08-13research articlehttp://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/20.500.13003/25716reponame:Docusalutinstname:Conselleria de Salut i Consum del Govern de les Illes BalearsInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Attribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:docusalut.com:20.500.13003/257162026-06-22T12:44:07Z
dc.title.none.fl_str_mv Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers
title Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers
spellingShingle Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers
Perachino, M
BRCA
breast cancer
oncofertility
pregnancy
survivorship
title_short Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers
title_full Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers
title_fullStr Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers
title_full_unstemmed Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers
title_sort Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers
dc.creator.none.fl_str_mv Perachino, M
Blondeaux, E
Delucchi, V
Bernstein Molho, R
Frank, S
Paluch-Shimon, S
Linn, S
Di Meglio, Antonio
Peccatori, F
Moore, H C F
Parokonnaya, A
Renaud, T
Rodriguez Wallberg, K A
Partridge, A H
Pogoda, K
Ferrari, A
Wildiers, H
Toss, A
Rousset-Jablonski, C
Kim, H J
Varela, M
Córdoba Cardona, Octavi
Tanase Damian, C
Marhold, M
Fabi, A
Graff, S L
Rodriguez-Hernandez, A
Okano, M
Duchnowska, R
Luna Pais, H
Di Rocco, R
Azim, H A
Mariamidze, E
Kourie, H R
Arecco, L
Carrasco, Estela
Agostinetto, E
Balmana, J
Saura, C
Lambertini, M
author Perachino, M
author_facet Perachino, M
Blondeaux, E
Delucchi, V
Bernstein Molho, R
Frank, S
Paluch-Shimon, S
Linn, S
Di Meglio, Antonio
Peccatori, F
Moore, H C F
Parokonnaya, A
Renaud, T
Rodriguez Wallberg, K A
Partridge, A H
Pogoda, K
Ferrari, A
Wildiers, H
Toss, A
Rousset-Jablonski, C
Kim, H J
Varela, M
Córdoba Cardona, Octavi
Tanase Damian, C
Marhold, M
Fabi, A
Graff, S L
Rodriguez-Hernandez, A
Okano, M
Duchnowska, R
Luna Pais, H
Di Rocco, R
Azim, H A
Mariamidze, E
Kourie, H R
Arecco, L
Carrasco, Estela
Agostinetto, E
Balmana, J
Saura, C
Lambertini, M
author_role author
author2 Blondeaux, E
Delucchi, V
Bernstein Molho, R
Frank, S
Paluch-Shimon, S
Linn, S
Di Meglio, Antonio
Peccatori, F
Moore, H C F
Parokonnaya, A
Renaud, T
Rodriguez Wallberg, K A
Partridge, A H
Pogoda, K
Ferrari, A
Wildiers, H
Toss, A
Rousset-Jablonski, C
Kim, H J
Varela, M
Córdoba Cardona, Octavi
Tanase Damian, C
Marhold, M
Fabi, A
Graff, S L
Rodriguez-Hernandez, A
Okano, M
Duchnowska, R
Luna Pais, H
Di Rocco, R
Azim, H A
Mariamidze, E
Kourie, H R
Arecco, L
Carrasco, Estela
Agostinetto, E
Balmana, J
Saura, C
Lambertini, M
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv
dc.subject.none.fl_str_mv BRCA
breast cancer
oncofertility
pregnancy
survivorship
topic BRCA
breast cancer
oncofertility
pregnancy
survivorship
description BACKGROUND: For women carrying a germline pathogenic or likely pathogenic variant in the BRCA1/2 genes, having a pregnancy following breast cancer diagnosis and treatment is safe. However, no evidence exists on the safety of having a subsequent pregnancy in BRCA carriers with a prior diagnosis of breast cancer during pregnancy (PrBC). METHODS: The BRCA BCY Collaboration (NCT03673306) is an international, multicenter, retrospective cohort study that included BRCA carriers diagnosed with invasive breast cancer at the age ≤40 years between January 2000 and December 2020. This analysis included only women diagnosed with PrBC comparing patients who had a subsequent pregnancy to those without. Primary endpoints were the cumulative incidence of having a subsequent pregnancy and disease-free survival (DFS). Secondary endpoints were overall survival, pattern of first DFS events and reproductive outcomes. RESULTS: Of 6238 BRCA carriers from 109 centers worldwide, 282 patients with PrBC were included in this analysis, of whom 68 had a subsequent pregnancy and 214 did not. The 10-year cumulative incidence of having a subsequent pregnancy was 36.6% [95% confidence interval (CI) 29.5% to 44.8%]. Patients with a subsequent pregnancy were more likely to be younger at diagnosis (median age 31 years versus 34 years) and to have triple-negative tumors (73.5% versus 55.1%). Among patients with a subsequent pregnancy, median time from diagnosis to conception was 3.3 years (interquartile range 2.0-4.3 years). Most pregnancies were delivered at term (≥37 weeks, 75.9%) and without complications (74.1%). Median follow-up was 7.3 years (interquartile range 4.5-11.9 years). No differences in DFS (adjusted hazard ratio (HR) 1.06, 95% CI 0.49-2.31) nor overall survival (adjusted HR 0.63, 95% CI 0.19-2.05) were observed between patients with or without a subsequent pregnancy. CONCLUSIONS: In this global study, one out of three young BRCA carriers diagnosed with PrBC had a subsequent pregnancy. No concerning signals in terms of maternal prognosis or reproductive outcomes were observed.
publishDate 2025
dc.date.none.fl_str_mv 2025
2025-08-13
2025
2025-08-13
dc.type.none.fl_str_mv research article
http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/20.500.13003/25716
url https://hdl.handle.net/20.500.13003/25716
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Docusalut
instname:Conselleria de Salut i Consum del Govern de les Illes Balears
instname_str Conselleria de Salut i Consum del Govern de les Illes Balears
reponame_str Docusalut
collection Docusalut
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869407933210558464
score 15.228081